Navigation Links
Luxcel Biosciences and HD Biosciences Enter Collaboration Agreement for Mitochondria Toxicity & Metabolism Assays for Preclinical Drug Safety Evaluation
Date:3/1/2017

CORK, Ireland and SHANGHAI, March 1, 2017 /PRNewswire/ -- Luxcel Biosciences Ltd (Luxcel), a Cork based Biotechnology Company and HD Biosciences Co., Ltd. (HDB), a leading preclinical drug discovery Contract Research Organization (CRO), announced today that they have entered a strategic partnership to co-market and provide new assay technologies for preclinical drug safety services. Under the agreement, HDB will gain access to Luxcel's state-of-the-art assays and technologies for assessment of mitochondrial function, toxicity and metabolism.

Mitochondrial dysfunction is a major contributor to drug-induced toxicity, post-market drug withdrawal and black box warnings for hepatic and cardiac toxicity. A major focus of the collaboration is the Respirometric Screening Technology (RST/OCR) assay, originally developed by Luxcel in collaboration with Pfizer Inc. (Ref: Will, Y et al (2006) Nature Protocols). A significant advance of the RST assay, versus the commonly used Glu/Gal assay, is its ability to accurately differentiate specific mitochondrial toxicity from non-specific toxicity, as well as un-couplers of mitochondrial function from inhibitors. The RST assay is fully validated in high throughput format and in weekly production mode at HDB, Shanghai, providing clients with the best mitochondrial toxicity assay available with cost effective and quick turnaround service.

RST Assay
RST Assay

"We are delighted to team up with Luxcel Biosciences Ltd, a leader in the field of optical sensing technologies." "HDB offers a full range of in vitro toxicology services including safety profiling panels (Safety Assess™), as well as cardiotoxicity, hepatotoxicity, genotoxicity and cytotoxicity screenings. Luxcel's growing portfolio of proprietary mitochondria toxicity, bioenergetics & metabolism assays, is highly complementary to our current offerings and provides early and effective identification of mitochondrial liabilities for our client's drug discovery programs," stated Dr. Peiyuan Lin, Senior VP of R&D Services of HDB.

"HDB has established and maintained a professional reputation globally with its pre-clinical service, bringing their clients the most up to date and valuable assays and tools to advance the drug discovery process. This joint effort will leverage the extensive expertise and capabilities from both sides, for the benefit of global as well as China-based pharmaceutical and biotech companies," said Dr. Ian Hayes, Commercial Director for Luxcel.

Contact Alanna Carty 148408@email4pr.com +353 86 2741539

About Luxcel Biosciences Ltd

Luxcel Biosciences was founded in 2002 in Co. Cork, Ireland, and is a multi-award winning provider of cost effective and easy to use fluorescence-based in vitro cell test kits, targeting cell metabolism, bioenergetics and drug toxicity applications.  Customers range from University research scientists, to global Pharmaceutical Companies and Contract Research Organisations.  Pfizer Inc., one of the world's largest pharmaceutical companies, is a key collaborator in the field of drug safety and mitochondrial toxicity screening. Several joint research publications in high impact journals have resulted from this successful collaboration.

www.luxcel.com

About HD Biosciences

HD Biosciences Co., Ltd. is a biology-focused preclinical drug discovery contract research organization (CRO) with headquarter in Shanghai, and operation facilities in Beijing and San Diego, USA. The company offers comprehensive research and development services to global pharmaceutical and biotech industries around target validation, plate-based pharmacology, hit identification & lead discovery, therapeutic antibody discovery, in vivo pharmacology, and other related areas. The company currently collaborates with eight (8) of the ten (10) largest pharmaceutical companies in the world and has established strategic partnerships with impacts to their portfolios. The strong scientific expertise, high quality of the services, consistency in deliveries, and constantly meeting or exceeding expectations, have helped the company to earn an excellent reputation in the industry. The in vitro pharmacology R&D and other core competencies of the company are widely recognized as one of the best among preclinical CROs.

About RST/OCA Assay

Please visit: http://www.hdbiosciences.com/EngRST.html

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luxcel-biosciences-and-hd-biosciences-enter-collaboration-agreement-for-mitochondria-toxicity--metabolism-assays-for-preclinical-drug-safety-evaluation-300415788.html


'/>"/>
SOURCE Luxcel Biosciences Ltd
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development
2. Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead Pharma, Pacific Biosciences of California, and Conatus Pharma
3. Fluxion Biosciences Appoints Genetracer Biotech of Spain As an Isoflux Liquid Biopsy Certified Service Provider
4. Vortex Biosciences Announces Commercial Launch of Fully Automated System for CTC Isolation
5. Caprion Biosciences wird Kurzlehrgang und Poster bei Molecular Medicine Tri-Conference in San Francisco präsentieren
6. CSO of Vortex Biosciences Dr. Elodie Sollier-Christen Awarded With 2017 SLAS Innovation Award
7. Swift Biosciences Expands Team, Hires Vice President of Marketing
8. ACEA Biosciences Announces Winners of its Travel Award
9. WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences
10. Vigilant Biosciences to Present at Medtech Showcase 2017 and BioLink 2017 China Healthcare Industry Investment and Licensing Conference
11. Avidity Biosciences Announces Publication on Targeting Therapeutic Oligonucleotides by Arthur A. Levin in the New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... and CARDIFF, UK (PRWEB) , ... June 23, 2017 , ... ... and Brian Lula, president of Physik Instrumente USA, have been selected as this year’s ... photonics . , The two have been invited along with other honorees to accept ...
(Date:6/23/2017)... ... 23, 2017 , ... The Academy of Model Aeronautics (AMA), ... Association (UAA), the unifying voice for collegiate aviation education, are launching a joint ... and success through a STEM-based education platform. , Much like the program currently ...
(Date:6/22/2017)... ... June 21, 2017 , ... RMC Pharmaceutical ... and engages Timothy Reinhardt to manage the new site. , Tim has 25 ... with his most recent role as the Director of Manufacturing and Supplier Quality ...
(Date:6/22/2017)... Wendelsheim, Germany (PRWEB) , ... June 22, 2017 ... ... , is taking over the allergy specialists DST Diagnostische Systeme & Technologien GmbH, ... We all know someone who suffers from hay fever, urticaria, asthma, atopic eczema ...
Breaking Biology Technology:
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Biology News(10 mins):